EGFR activating mutations detected by different PCR techniques in Caucasian NSCLC patients with CNS metastases: short report

Abstract

EGFR mutation testing has become an essential determination to decide treatment options for NSCLC. The mutation analysis is often conducted in samples with low percentage of tumour cells from primary tumour biopsies. There is very little evidence that samples from metastatic tissues are suitable for EGFR testing. We had evaluated the frequency of EGFR… (More)
DOI: 10.1007/s10585-013-9603-8

6 Figures and Tables

Topics

  • Presentations referencing similar topics